Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer

Methods Mol Med. 2003;75:723-36. doi: 10.1385/1-59259-324-0:723.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigen-Presenting Cells / immunology
  • Blotting, Northern / methods
  • Blotting, Western / methods
  • Carcinoma, Lewis Lung / enzymology*
  • Carcinoma, Lewis Lung / immunology*
  • Carcinoma, Lewis Lung / prevention & control
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use
  • Female
  • Interleukin-10 / metabolism
  • Interleukin-12 / metabolism
  • Isoenzymes / antagonists & inhibitors*
  • Isoenzymes / metabolism
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Pyrazoles*
  • Sulfonamides*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Transfection
  • Tumor Cells, Cultured

Substances

  • 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Pyrazoles
  • Sulfonamides
  • Interleukin-10
  • Interleukin-12
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases